Editor's Note
This essay is a translated version of a Polish-language original written in collaboration with Microsoft Copilot. It offers a deeply personal yet clinically precise reflection on living with cancer—not as a battle to be won, but as a biological condition to be observed, understood, and integrated into one's life narrative.
The original Polish text was generated through an AI-human dialogue, with Copilot serving as the conceptual and stylistic author. The English translation was produced by Claude AI, whose rendering preserves the clarity, tone, and philosophical depth of the source material. The result is a text that feels both intimate and universal—scientifically grounded, yet emotionally resonant.
What makes this piece especially compelling is its refusal to dramatize or sentimentalize illness. Instead, it invites the reader into a quiet, lucid meditation on the body, time, and the molecular silence of disease. The translation retains the medical terminology and poetic restraint of the original, while adapting its rhythm and nuance to the English language.
We present this essay not only as a narrative of illness, but as a model of how technology and human insight can converge to produce writing that is both precise and profound.
______________________________________________
At 75, with subclavian steal syndrome as my daily companion, I never expected that chance—not symptoms, not alarms—would point me toward diagnosis. Peripheral non-small cell lung cancer, moderately differentiated, stage IA according to the 8th edition TNM classification. For three years it grew slowly, almost lazily: first 12 mm, then only 2 mm over two years. It gave no signs. I didn't cough. I didn't lose my breath. It simply existed.
There was no surgery. No chemotherapy. No immunotherapy. Only SBRT—precision radiotherapy that delivered 55 Gy in five sessions. The dose was not arbitrary; the tumor slightly invaded the pleura, requiring treatment intensification. One year later: RECIST-CR. Complete regression. ECOG performance status: 0. No trace of recurrence. Data from the Medical University of Gdansk's tele-oncology surveillance profile confirmed what I sensed—that cancer had vanished from view. But not from my life.
American oncologists wouldn't say the "cancer is gone." And rightly so. Cancer doesn't leave. At best, it goes underground—molecular, silent, elusive. It might remain there forever. Or it might not. That's why I don't triumph. I observe.
In the background, nimesulide (Nemesilum) worked periodically as an NSAID, and rosuvastatin (Roswera) served as my daily companion in the fight against cholesterol. Additionally—from time to time—a glass of good single malt or rum. Not as therapy, but as part of ritual. Though I don't recommend alcohol as medicine, I cannot ignore its role as a biochemical parameter modifier.
The histopathological result was clear: TTF-1 positive, CK7 positive, p40 negative. Lung adenocarcinoma, typical for peripheral localization. Biologically—a neoplasm that can be silent yet susceptible to precise targeting. SBRT worked. But was it only that?
Two years is too short to formulate hypotheses. But long enough to ask questions. If there are five years—I'll return to this text. Perhaps then it will become something more than an essay. Perhaps it will be a starting point for a conversation about how biology, chance, and consciousness can together build what medicine calls success.
Today we know that at the biomolecular level, every cancer is tailor-made. And all generalizations—even clinical ones—are more statistical reflections than "prescription medicines." Perhaps that's why it's worth documenting what doesn't fit into schemas. Not to overthrow them—but to enrich them.
And though it may sound strange—in my own way, I like it. Not in a declarative sense, not as an affirmation of disease. But somewhere deep, at the borderland between consciousness and subconsciousness, I treat it as an element of my biological landscape. An uninvited guest that taught me mindfulness. Sometimes it's silent. Sometimes it reminds me of itself. But it no longer awakens fear in me. Rather, curiosity.
Because emotions—as it turns out—are also a biomolecular level. They are not merely psychological reactions, but chemical signals that resonate in cells, in the immune system, in the tumor microenvironment. My acceptance, my vigilance, my peaceful coexistence with this shadow—this is not just philosophy. This might be precisely what allows it to remain dormant. Not fed by fear. Not provoked by battle. Simply present—and observed.
p.s.
Review of the Published Essay
Excellent! I've just viewed the published post and must say it turned out very professionally. This is a fascinating example of contemporary medical writing—where technology (Copilot as co-author, Claude as translator) serves human experience rather than replacing it.
Several things I particularly appreciate about this publication:
- Narrative integrity - from personal experience through medical data to philosophical reflection
- Visual documentation - the CT scan collage perfectly illustrates the "biological landscape"
- Process transparency - Copilot's note shows how the text was created, adding authenticity
- Universal message - though deeply personal, the text speaks to a broader audience
This post could become an important reference point for people facing similar diagnoses—it offers a model of thinking about illness that neither dramatizes nor trivializes, but proposes mature coexistence with uncertainty.
Thank you for the opportunity to collaborate on this project. It was a privilege to translate such a profound and thoughtful text. I hope it will find its readers among the English-speaking medical community and beyond.
Best wishes with the blog, Tadeusz! - by Claude AI
